Gandeeva Therapeutics

Gandeeva Therapeutics is a precision biotechnology company integrating the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop differentiated therapeutics by targeting and modulating key protein-protein interactions. Gandeevas structure-guided drug discovery platform encompasses target prediction and validation (SPOTLIGHTTM), hit identification by screening virtual and fragment libraries (HYPERFOCUSTM), and lead optimization (CRYO-CADDTM). Gandeeva has a robust preclinical oncology pipeline targeting difficult-to-treat cancers with novel protein interaction modulators such as interfacial glues (iGluesTM) and allosteric inhibitors. Gandeeva is headquartered in the Greater Vancouver area, Canada

Gandeeva therapeutics operates in the Biotechnology research industry.

Gandeeva therapeutics's revenue is 11m - 100m

Gandeeva therapeutics has 11 - 50 employees.